Reliability
by Design
Custom assembly design, vertically integrated supply, and proactive regulatory alignment are converging into a single standard of performance for single-use fluid management in biopharmaceutical manufacturing.
The Tolerance for Assembly-Level Variability Has Reached Zero
Single-use assemblies were once evaluated primarily on cost and convenience. That calculus has changed. As biomanufacturing pipelines grow more complex — encompassing mRNA vaccines, viral vectors, and cell and gene therapies alongside traditional monoclonal antibodies — a batch loss or process failure traced to a misfit connector carries the same consequence as an equipment breakdown.
The industry has responded by demanding that reliability be engineered in from the beginning, not verified after the fact. Three mutually reinforcing disciplines define what that looks like in practice: custom assembly design built on validated components, vertical integration that makes traceability a supply chain property, and regulatory alignment embedded at the assembly level for Annex 1, PUPSIT, and USP<665>.
This white paper examines each discipline in detail and draws on SaniSure’s custom assembly and fluid management platform as a reference for how all three can operate together within a single supply relationship.
The paper covers:- How validated component libraries enable configuration changes without requalification
- Why vertical integration eliminates the principal sources of inter-vendor dimensional variability
- How assembly-level design choices propagate into PUPSIT and Annex 1 outcomes
- The shift from BPOG solvent-extraction to USP<665> and what it demands from suppliers
What Engineered Reliability Looks Like in Practice
Three mutually reinforcing disciplines that, taken together, shift reliability from a post-manufacture finding to a designed-in property.
A qualified library of tubing formulations, molded connectors, closures, and filter interfaces functions as an interchangeable design vocabulary. Engineers configure tubing length, connector geometry, dip-tube orientation, or filter staging without triggering component-level requalification — because the underlying materials are already characterized.
End-to-end manufacturing control — from resin sourcing through extrusion, injection molding, cleanroom assembly, and gamma sterilization within a single quality system — eliminates the principal sources of inter-vendor variability. Certificates of Conformance are unified rather than assembled from multiple vendor packages.
EU GMP Annex 1 (2022) requires every connection point in a sterile fluid path to be assessed and documented within a facility-wide CCS. Assemblies backed by unified mechanical qualification data and standardized extractables documentation integrate into that framework naturally — rather than requiring reconstruction from multiple vendor sources.
The Three Disciplines
in Detail
How each discipline addresses a specific failure mode in conventional single-use supply, and what the practical payoff looks like for qualification and regulatory teams.
Assemblies developed at 20-liter scale transfer to 200-liter GMP operations with identical documentation and qualification data, because new configurations are built from pre-validated building blocks rather than novel materials. Risk assessments draw on established data; new extraction studies are triggered only when genuinely novel materials or conditions are introduced. Closed, pre-sterilized assemblies with fixed tubing layouts eliminate operator-dependent assembly steps and remove preparation overhead in controlled environments.
When every step from resin lot selection to finished-product release is captured within a single QMS, extractables data link directly to the specific resin, processing conditions, and sterilization cycle associated with that assembly — not a generic material characterization. Dimensional tolerances are validated against actual connector geometries; sterilization parameters are qualified against the specific polymer formulations being irradiated. This level of traceability directly simplifies risk assessments under ICH Q9(R1) and facility contamination control strategy frameworks.
PUPSIT exposes how assembly design choices propagate directly into regulatory outcomes: a connection defect that produces erratic pressure profiles during integrity testing can either generate a false failure or, more critically, mask a real filter defect. Pull-force evaluation, burst testing, and pressure-decay testing of every connection point address this systematically. On extractables, the shift from legacy BPOG frameworks to USP<665> / USP<1665> has raised the bar for specificity — suppliers who provide extractables data linked to specific resin lots and processing parameters significantly reduce leachables risk assessment burden for end-users.
Pre-validated building blocks allow process-specific customization without new extraction studies for each configuration change.
A single quality system delivers one Certificate of Conformance rather than assembling records from multiple vendor packages.
Assembly-level mechanical qualification ensures pressure integrity results reflect genuine filter integrity — not connection variability.
USP<665>-aligned E&L data linked to specific resin lots and processing parameters reduces leachables risk assessment time at submission.
Reliability is a designed-in property, not a verified one. When all three disciplines operate within a single supply relationship, qualification timelines shorten, regulatory submissions carry more complete documentation, and batch performance scales predictably.
Where Conventional Single-Use Supply Approaches Create Risk
Biopharmaceutical manufacturers rely on single-use fluid management assemblies at every upstream and downstream step — from media and buffer preparation through fill and finish. When the supply model introduces its own variability through disconnected vendor relationships, generic documentation, or post-manufacture verification, the assembly becomes a source of process risk rather than a controlled component of it.
| Approach | Root Cause | Process Consequence |
|---|---|---|
| Multi-vendor assembly supply chain | Component tolerances validated independently by separate suppliers, not against each other | Dimensional mismatches at connection points; PUPSIT failures that cannot be traced to the filter versus the assembly |
| Generic or BPOG-format extractables data | E&L characterization performed on material class, not specific resin lots or processing conditions | Extended leachables risk assessment timelines; potential regulatory challenge when lot-to-lot variation in a material cannot be explained |
| Post-manufacture reliability verification | No unified specification across all materials in the fluid path at the design stage | Batch loss; deviation investigations; reproducibility gaps when scaling from development to GMP production |
| Disconnected documentation at qualification | Multiple vendor CoCs assembled rather than generated from a single quality system | Contamination Control Strategy gaps under Annex 1; increased burden to demonstrate traceability at audit |
Custom Fluid Management Assemblies Built for GMP
SaniSure’s custom assembly and fluid management platform implements all three disciplines of engineered reliability within a single supply relationship. A validated component library spanning TPE, silicone, Cellgyn, and Pharma-Line I TPV tubing formulations, PharmaTainer bottle systems, and filtration interfaces provides the design vocabulary for process-specific configurations without triggering component-level requalification.
Vertically integrated production across Americas and EMEA facilities, combined with a single quality system, ensures dimensional tolerances are validated against actual connector geometries, sterilization parameters are qualified against the specific polymer formulations being irradiated, and extractables data are linked to the resin lots and processing conditions associated with each assembly.
- Validated component library: TPE, silicone, Cellgyn, Pharma-Line I TPV, PharmaTainer systems
- USP<665>-aligned extractables data linked to specific resin lots and processing parameters
- PUPSIT-compatible configuration testing: pull-force, burst, and pressure-decay per connection point
- Single QMS across all manufacturing steps from resin to finished-product release
- Americas and EMEA dual-region manufacturing for supply continuity
Management
Assemblies
Process-specific single-use fluid management assemblies built from a validated component library — configured without triggering requalification, documented within a unified quality system, and manufactured across dual regions for supply continuity in GMP operations.
- Validated component library — configure without requalification
- USP<665> extractables data linked to specific resin lots
- PUPSIT-compatible mechanical validation per assembly
- Unified CoC and QMS across all manufacturing steps
- Americas and EMEA dual-region manufacturing
at the Design Stage.
Whether you’re qualifying a new single-use platform, preparing for an Annex 1 audit, or transferring a process to GMP scale, our team can walk you through how SaniSure’s custom assembly platform maps to your specific requirements.